Vaping Research and Public Health

Thursday 16th June 15:15 - 16:30

No Stream

This video session is for members only.

Log in here to watch this session

Log in

Not yet a member of World Vape Show? Click here to join free

What is driving the misinformation on vaping? The Scientific evidence and research have led many government agencies, public health bodies and health charities to hail vaping as a magic bullet to reduce smoking rates. Whilst there is growing evidence of vaping's benefits to public health versus smoking why are some jurisdictions looking to ban them?

Is there more research that needs to be done. This panel will look at where the remaining gaps in evidence are - and how we can fill them.

Moderator:

John Dunne, Director General, UK Vaping Industry Association (UKVIA) and Managing Director of Dyflin Group Consulting

Ultrasound: The future of nicotine vaping

  • Professor Imad Lahoud, CTO, Medad Technology (VIRTUAL)


An update on the science of nicotine vaping

  • Dr Colin Mendelsohn, Founding Chairman, Australian Tobacco Harm Reduction Association

Panellists:

  • Dr Ignacio Gonzalez Suarez, Head of Scientific Engagement, Philip Morris International
  • Professor Imad Lahoud, CTO, Medad Technology (VIRTUAL)
  • Dr Colin Mendelsohn, Founding Chairman, Australian Tobacco Harm Reduction Association
  • Dr Hugo Tan, Regional Head of Scientific Engagement, BAT Asia Pacific and Middle East
  • Fred Roeder, Managing Director, Consumer Choice Centre

Speakers

John Dunne

Director General

UK Vaping Industry Association (UKVIA)

John has a strong background and reputation in the European e-cigarette industry, having held senior executive positions in some of the US and Europe’s biggest companies. As Managing Director of Dyflin Group Consulting, he advises many leading industry analysts, financial institutions and media organisations looking at the vaping and CBD sectors. John is also Director-General and one of the founders of the UK Vaping Industry Association (UKVIA), the UK’s largest vaping Industry association and has advised the UK governments All Party Parliamentary Group on Vaping as well as giving evidence before the UK Science & Technology Committee investigation into the Vaping industry and the Australian Parliaments review on vaping.

John regularly appears on national television, radio as well as national and international print media. John is a popular guest speaker at many of the world’s leading conventions.

Dr Ignacio Gonzalez Suarez

Head of Scientific Engagement Middle East and Africa

Philip Morris International

Ignacio Gonzalez Suarez, Spanish by origin, holds a PhD in Biochemistry and Molecular Biology, and a BSc in Biochemistry from the University of Oviedo (Spain).

At Philip Morris International, he is responsible for engaging and sharing the science behind PMI’s smoke-free products to increase awareness and understanding of tobacco harm reduction for the Middle East and Africa countries.

He has more than 15 years of experience in preclinical models of disease. Throughout his career he has published over 40 scientific publications and book chapters, and participated in numerous national and international scientific congresses.

Professor Imad Lahoud

CTO

Medad Technology

Professor Imad Lahoud is the Chief Technology Officer at Medad Technology, heading their R&D and manufacturing. Under his leadership, a team of scientists and engineers are spearheading disruptive innovations in HealthTech, BioTech and Power Management.

Professor Lahoud has dedicated 20 years to the aerospace industry and has co-headed the R&D and Innovations Department for industry giants such as Airbus.

He holds a PhD in Computer Science and a Professorship in Mathematics and has taught in the French Elite system of “Preparation aux Granges Ecoles” and at the University of Denis Diderot.

Dr Colin Mendelsohn

Founding Chairman

Australia Tobacco Harm Reduction Association

Colin is a medical practitioner who works in Sydney, Australia exclusively in tobacco treatment, with a special interest in harm reduction. He is also the author of a recently published book, Stop Smoking Start Vaping - The Healthy Truth about Vaping.

He is a member of the expert advisory group that develops the Australian national smoking cessation guidelines. He is the Founding Chairman of the Australian Tobacco Harm Reduction Association, a health promotion charity established to raise awareness of tobacco harm reduction.

Colin was previously a Conjoint Associate Professor in the School of Public Health and Community Medicine at the University of New South Wales.

He is currently an investigator on a government-funded clinical trial on vaping at the National Drug and Alcohol Centre.

For more information, www.colinmendelsohn.com.au

Fred Roeder

Managing Director

Consumer Choice Centre

Fred Roeder (Managing Director of the Consumer Choice Center) is a consumer advocate at heart. He has been working in health policy for over ten years. He is a Health Economist from Germany and has worked in healthcare reform in North America, Europe, and the Caucasus. One of his passions is to analyze how disruptive industries and technologies allow consumers more choice at a lower cost. He also loves researching how innovation makes our lives better.

Fred is very interested in consumer choice and regulatory trends in the following industries: Consumer Goods, Healthcare, Sharing Economy, and Airlines.

Among many op-eds and media appearances, he has been published in the Frankfurter Allgemeine Zeitung, Wirtschaftswoche, Die Welt, the BBC, BILD, Arabian Business, The National, ABC Portland News, Montreal Gazette, Daily Mail, Handelsblatt, Huffington Post Germany, CityAM. L’Agefi, and The Guardian.

Dr Hugo Tan

Regional Head of Scientific Engagement

BAT Asia Pacific and Middle East

Dr Hugo is a trained medical physician and is registered with the Malaysia Medical Council. He practiced general community medicine in both major government and private hospitals in Kuala Lumpur, Malaysia before moving into multinational pharmaceutical companies including GlaxoSmithKline, Novartis, and AstraZeneca.

In these positions, he led and managed large teams of medical advisors and regulatory affairs associates for 14 years, in local as well as regional roles as a medical affairs expert. He also worked with leading researchers in late phase clinical trials and partnered with start-ups to bring innovative medicine from early development to commercialisation.

Hugo joined BAT in February 2022 as the Head of Scientific Engagement for the Asia Pacific and Middle East region, encompassing more than 13 countries. In this role, Hugo is responsible for collaborating with regional and local public health advocates to advance understanding and research in Tobacco Harm Reduction.

JOIN OUR MAILING LIST

Be the first to hear about exhibitors, speakers and what's on at our upcoming events.

Which events are you interested in? *
I'm interested in *